New Delhi: Amid studies of scarcity of Remdesivir which is thought for its effectiveness within the therapy of COVID-19, the federal government of India has warned of strict action against those that take pleasure in hoarding or black marketing of the drug.
Union Health Minister Dr Harsh Vardhan on Wednesday (April 14) mentioned that those that are creating synthetic scarcity of the medication must face strict action.
“Drugs Controller General of India (DGCI) has directed for strict action into any complaint of black marketing of Remdesivir. Those who are exploiting people and creating artificial shortage of medicine, strict action should be taken against them,” Dr Harsh Vardhan was quoted as saying by ANI.
Harsh Vardhan additionally mentioned that the manufacturing of Remdesivir shall be ramped as much as meet the rising demand amid COVID-19 surge.
“Shortage of Remdesivir happened because its production was reduced as COVID-19 cases were decreasing. Our drug controller and ministry held a meeting with stakeholders and asked manufacturers to strengthen the production,” he mentioned.
Union Minister of State for Chemical and Fertilizers Mansukh Mandaviya additionally held conferences to debate the difficulty of Remdesivir availability. He mentioned that the manufacturing capability of the drug can be elevated.
“Current total capacity of 7 manufacturers of Remdesivir is 38.80 lakh vials/month. Fast-track approval was given for 7 more sites having production capacity of 10 Lakh vials/month to 6 manufacturers. Another 30 lakh vials/month production lined up,” a press release from the ministry mentioned.
